Onconetix, Inc. (ONCO)
1.62
+0.03
(+1.89%)
USD |
NASDAQ |
Jan 15, 16:00
1.50
-0.12
(-7.41%)
After-Hours: 20:00
Onconetix EPS Diluted (Quarterly): -6.250 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.784M |
| Revenue (Quarterly) | 0.3037M |
| Total Expenses (Quarterly) | 9.087M |
| Enterprise Value | 0.1613M |
| Gross Profit Margin (Quarterly) | 88.54% |
| Profit Margin (Quarterly) | -2.89K% |
| Earnings Yield | -16.72K% |
| Normalized Earnings Yield | -6360.66 |